background
serolog
studi
influenza
infect
vaccin
respons
often
involv
microneutr
hemagglutin
inhibit
assay
evalu
neutral
antibodi
human
avian
influenza
virus
includ
previous
character
lentivir
particl
pseudotyp
valid
assay
safe
altern
highthroughput
serolog
studi
facil
show
differ
clade
alway
give
rise
effici
product
underli
mechan
address
methodologyfind
carri
mutat
analysi
delin
molecular
determin
respons
effici
packag
ha
result
demonstr
singl
mutat
receptor
bind
domain
suffici
render
abil
gener
effici
wherea
revers
mutat
greatli
hamper
product
although
protein
express
total
cell
lysat
similar
cell
surfac
express
detect
significantli
higher
level
demonstr
sever
independ
line
evid
behaviour
explain
stronger
bind
sialic
acid
receptor
implic
residu
identifi
singl
mutat
molecular
determin
effici
incorpor
envelop
delin
underli
mechan
reduc
bind
sialic
acid
receptor
result
mutat
exert
critic
influenc
pseudotyp
effici
also
impact
whole
viru
level
substitut
report
natur
occur
mutat
human
host
result
may
implic
understand
human
host
adapt
avian
influenza
virus
influenza
viru
highli
pathogen
poultri
certain
bird
popul
occasion
infect
human
caus
sever
clinic
outcom
sinc
first
human
outbreak
confirm
human
case
infect
mortal
rate
approxim
initi
infect
like
subtyp
influenza
virus
viru
first
bind
cell
surfac
glycan
receptor
via
surfac
glycoprotein
hemagglutinin
ha
subsequ
intern
via
endocyt
pathway
ha
homotrimer
type
transmembran
glycoprotein
cleav
subunit
furindepend
polybas
cleavag
site
shown
characterist
highli
pathogen
avian
influenza
virus
although
contain
polybas
cleavag
site
cell
infect
influenza
viru
ha
protein
first
synthes
precursor
oligomer
glycosyl
ultim
transport
plasma
membran
assembl
bud
progeni
virion
take
place
final
stage
viru
life
cycl
neuraminidas
na
second
major
envelop
glycoprotein
influenza
cleav
termin
sialic
acid
cell
surfac
glycan
allow
releas
viru
host
cell
follow
first
report
outbreak
viru
evolv
differ
clade
shown
phylogenet
analysi
protein
sequenc
current
spread
viru
human
popul
limit
howev
mutat
reassort
viru
may
becom
easili
transmiss
bird
human
human
human
pose
potenti
pandem
threat
public
health
worldwid
therefor
import
fulli
understand
biolog
virus
develop
sensit
rapid
diagnost
method
howev
obstacl
studi
virus
stringent
safeti
requir
work
recent
research
group
develop
retrovir
particl
pseudotyp
altern
strategi
larg
scale
serolog
studi
similar
replicationcompet
viru
entri
requir
sialic
acid
phdepend
neutral
sera
contain
antibodi
thu
valid
use
safe
tool
wide
rang
applic
includ
entri
mechan
studi
serodiagnosi
drug
discoveri
previou
work
produc
use
isol
patient
lethal
infect
viru
current
studi
analyz
abil
differ
clade
avian
influenza
viru
pseudotyp
lentivir
particl
found
give
rise
level
effici
product
compar
particular
carri
detail
comparison
express
cleavag
two
ie
aanhui
abil
pseudotyp
lentivir
vector
cell
sever
independ
line
evid
identifi
molecular
determin
effici
incorpor
envelop
delin
underli
mechan
result
discuss
context
understand
human
host
adapt
avian
influenza
virus
abil
pseudotyp
lentivir
particl
correl
ha
protein
express
level
produc
cell
similar
ha
subtyp
influenza
virus
highli
mutabl
result
antibodyselect
pressur
lead
rise
diverg
virus
categor
variou
strain
clade
ascertain
flexibl
adapt
product
altern
approach
serolog
studi
event
novel
emerg
virus
sought
develop
cladespecif
compar
abil
three
virus
belong
differ
clade
pseudotyp
lentivir
particl
clade
clade
clade
clade
see
tabl
express
cell
togeth
lentivir
backbon
plasmid
allow
product
lentivir
particl
express
level
transfect
cell
monitor
western
blot
use
antiflag
antibodi
direct
ctermin
tag
fig
upper
panel
supernat
contain
harvest
hr
posttransfect
use
transduc
mdck
cell
luciferas
report
activ
assay
fig
lower
panel
describ
materi
method
unexpectedli
observ
signific
differ
transduct
mdck
cell
depend
clade
particular
result
low
luminesc
level
particl
transduct
mdck
cell
wherea
effici
induc
consist
log
increas
luciferas
activ
compar
fig
b
lower
panel
analysi
cell
lysat
western
blot
howev
demonstr
test
well
express
produc
cell
consequ
luciferas
report
activ
mdck
target
cell
correl
level
ha
protein
express
cell
fig
two
main
protein
band
detect
consist
expect
electrophoret
mobil
uncleav
protein
ctermin
portion
cleav
form
subunit
wherea
ntermin
fragment
subunit
could
recogn
antiflag
antibodi
due
ctermin
tag
fig
next
decid
compar
detail
behaviour
determin
whether
differ
luciferas
report
activ
due
level
product
cultur
supernat
contain
concentr
ultracentrifug
result
pellet
analyz
western
blot
result
show
number
particl
produc
cultur
supernat
significantli
less
presenc
solubl
bacteri
neuraminidas
indic
lower
level
concentr
supernat
detect
lentivir
core
lower
luciferas
report
activ
mdck
cell
fig
importantli
incorpor
pseudotyp
lentivir
particl
observ
use
antiflag
antibodi
fig
upper
panel
altogeth
data
suggest
effici
incorpor
pseudotyp
particl
releas
cell
cultur
supernat
swap
domain
includ
polybas
cleavag
site
increas
product
sequenc
analysi
polybas
cleavag
site
reveal
delet
lysin
residu
compar
moreov
addit
amino
acid
differ
region
posit
locat
border
ectodomain
transmembran
domain
tmd
fig
thu
isoleucin
posit
threonin
cleavag
ha
subunit
host
proteas
critic
step
influenza
virus
gain
membran
fusion
capabl
wherea
tmd
ha
import
associ
lipid
raft
plasma
membran
test
potenti
influenc
differ
cleavag
site
posit
gener
sever
chimer
construct
either
entir
region
includ
cleavag
site
replac
cleavag
site
singl
amino
acid
chang
introduc
construct
flagtag
ctermin
end
sequenc
describ
materi
method
section
fig
transfect
cell
three
mutant
protein
well
express
produc
cell
lysat
fig
howev
analysi
transduct
level
mdck
target
cell
produc
chimer
protein
suggest
none
abl
increas
product
pseudotyp
particl
fig
data
indic
differ
domain
account
reduc
abil
form
pseudotyp
particl
two
amino
acid
substitut
receptor
bind
domain
rbd
suffici
confer
pseudotyp
abil
sequenc
align
protein
reveal
strike
amino
acid
diverg
posit
short
stretch
region
around
rbd
tabl
account
amino
acid
differ
found
entir
ha
molecul
amino
acid
length
therefor
region
chosen
sitedirect
mutagenesi
gener
seri
mutant
subsequ
test
abil
pseudotyp
lentivir
vector
level
protein
express
mutant
produc
cell
compar
albeit
slightli
lower
fig
interestingli
mutant
harbor
residu
alaninevalin
posit
tabl
display
larg
restor
abil
produc
pseudotyp
particl
despit
sequenc
differ
flank
region
fig
contrast
contain
flank
sequenc
serinealanin
posit
gener
effici
cultur
supernat
fig
data
clearli
demonstr
amino
acid
residu
posit
crucial
effici
product
specif
substitut
two
amino
acid
uniqu
sequenc
confer
abil
incorpor
lipid
envelop
lentivir
particl
essenti
effici
product
transductioncompet
singl
mutat
rbd
critic
determin
product
delin
respect
role
effici
pseudotyp
two
addit
mutant
gener
singl
amino
acid
substitut
either
posit
tabl
experi
reveal
mutat
suffici
confer
abil
incorpor
transductioncompet
pseudoparticl
wherea
mutat
fig
also
gener
reciproc
mutant
contain
either
two
residu
found
posit
viz
one
singl
chang
substitut
tabl
presenc
valin
posit
found
crucial
effici
product
wherea
substitut
margin
effect
consist
result
obtain
mutant
fig
confirm
effect
valin
posit
inde
product
analyz
western
blot
cellular
lysat
cultur
supernat
contain
concentr
ultracentrifug
fig
seri
experi
show
incorpor
anhuilik
singl
mutant
pseudotyp
lentivir
particl
antibodi
detect
limit
also
seen
wildtyp
wherea
cambodialik
singl
mutant
induc
product
effici
similar
fig
altogeth
experi
demonstr
valin
posit
critic
residu
effici
product
mutat
affect
cell
surfac
express
level
ha
influenza
viru
well
particl
pseudotyp
ha
bud
plasma
membran
reason
chang
surfac
express
could
impact
product
thu
compar
flow
cytometri
plasma
membran
express
level
ha
protein
cell
transfect
cell
label
antibodi
fix
stain
peconjug
secondari
antibodi
assess
measur
mean
fluoresc
intens
mfi
cell
surfac
express
significantli
less
compar
fig
interestingli
introduct
mutat
increas
cell
surfac
express
fig
convers
mutat
reduc
transport
plasma
membran
level
significantli
differ
measur
fig
data
demonstr
ala
val
substitut
posit
enhanc
surfac
express
residu
receptor
bind
site
next
investig
impact
mutat
receptor
bind
properti
employ
cellbas
assay
use
solubl
protein
engin
remov
tmd
ctail
ha
fig
describ
materi
method
stabl
cell
line
gener
express
reciproc
singl
amino
acid
mutant
form
bear
see
also
tabl
solubl
ha
protein
affinitypurifi
describ
materi
method
analyz
nativ
gel
purifi
solubl
protein
contain
mostli
homotrimer
form
fig
bind
sialic
acidcontain
cellular
receptor
observ
bound
strongli
mdck
cell
wherea
mutat
reduc
bind
much
lower
level
fig
contrast
bound
weakli
mdck
cell
predict
singl
chang
induc
major
increas
bind
mdck
cell
fig
bind
assay
also
perform
cell
express
twofold
higher
amount
sialic
acid
parent
mdck
cell
result
obtain
similar
parent
mdck
cell
fig
cell
treat
bacteri
neuraminidas
navb
fixat
pfa
bind
sha
protein
diminish
background
level
mdck
cell
indic
bind
sha
protein
sialic
acid
depend
fig
previous
found
hivbackbon
bud
plasma
membran
cell
reduc
cell
surfac
express
viral
envelop
protein
see
fig
would
expect
influenc
format
pseudotyp
particl
henc
could
account
observ
differ
pseudotyp
report
retrovirus
includ
hiv
murin
leukemia
viru
mlv
also
bud
intracellular
compart
depend
cell
type
gag
express
system
therefor
also
use
mlvbase
pseudotyp
system
compar
effici
product
demonstr
fig
result
obtain
mlvbackbon
similar
hivbackbon
thu
indic
ineffici
product
mere
consequ
lentivir
system
use
pseudotyp
howev
cotransfect
viral
na
rescu
ineffici
product
fig
test
whether
reduc
bind
sialic
acid
receptor
result
mutat
major
contribut
factor
pseudotyp
effici
examin
product
cell
sialylationdefici
mutant
cho
cell
bind
weakli
sialic
acid
receptor
fig
navb
ad
exogen
post
transfect
suffici
releas
cultur
supernat
cho
cell
level
cho
cell
significantli
differ
cell
fig
similar
result
obtain
cell
product
lower
cho
cell
contrast
product
cell
significantli
increas
comparison
parent
cho
cell
level
obtain
cell
similar
indic
valu
luciferas
activ
detect
mdck
cell
hr
post
transduct
fig
togeth
find
suggest
bind
cellular
sialic
acid
contain
glycan
major
determin
incorpor
pseudoparticl
virus
carri
mutat
exhibit
reduc
capabl
agglutin
hors
red
blood
cell
reduc
bind
sialic
acid
receptor
result
mutat
lead
chang
pseudotyp
effici
also
found
impact
whole
viru
level
revers
genet
gener
mutat
shown
agglutin
degre
human
red
blood
cell
rbc
express
acid
guinea
pig
rbc
exhibit
sialic
acid
fail
agglutin
hors
rbc
carri
acid
observ
provid
experiment
evid
support
notion
mutat
lead
reduc
acid
bind
viru
confirm
effect
mutat
virus
perform
similar
hemagglutin
assay
use
anoth
viru
strain
acambodia
also
contain
mutat
previou
studi
report
gener
character
safe
altern
use
replic
viru
serosurveil
mimic
entri
mechan
avian
viru
carri
envelop
protein
offer
advantag
specif
neutral
antihemagglutinin
antibodi
avoid
confound
effect
antibodi
direct
neuraminidas
due
infect
influenza
viru
subtyp
report
effici
gener
haonli
vari
deriv
differ
viru
clade
regardless
lentivir
backbon
use
serial
mutagenesi
two
uncov
differ
receptor
bind
abil
due
mutat
receptorbind
domain
ha
may
underli
mechan
wide
believ
ha
target
lipid
raft
plasma
membran
transmembran
domain
describ
import
lipid
raft
associ
ha
therefor
first
swap
transmembran
region
also
notic
cleavag
appear
effici
fig
thu
mutant
without
sequenc
variat
found
polybas
cleavag
site
gener
analys
howev
none
mutant
show
appreci
improv
abil
gener
compar
wild
type
fact
product
trypsindepend
pseudoparticl
report
henc
indic
ha
cleavag
determin
factor
pseudotyp
effici
multipl
sequenc
align
identifi
small
region
around
receptor
bind
site
ha
appear
hotspot
harbor
sever
sequenc
variat
among
differ
clade
seri
mutagenesi
studi
found
one
singl
residu
posit
critic
switch
dictat
abil
ha
pseudotyp
lentivir
vector
product
similar
influenza
viru
gener
hivbackbon
bud
plasma
membran
therefor
simplest
explan
mutat
posit
may
result
chang
cell
surfac
express
ha
inde
observ
small
consist
chang
cell
surfac
ha
express
due
mutat
posit
fig
exclud
possibl
find
mere
reflect
differenti
bind
two
ha
rabbit
polyclon
serum
describ
materi
method
use
anoth
polyclon
serum
differ
sourc
duck
serum
describ
ref
found
result
cell
surfac
ha
stain
similar
data
shown
fact
mutat
increas
cell
surfac
express
may
partial
explain
effect
amino
acid
substitut
product
consid
variat
product
result
log
differ
luciferas
activ
like
mutat
may
impact
properti
includ
bind
sialic
acid
receptor
contribut
observ
phenotyp
report
case
pseudotyp
lentivir
particl
incorpor
sialic
acid
bindingincompet
deriv
effici
gener
releas
cultur
supernat
absenc
exogen
bacteri
na
wherea
wildtyp
aichiha
fail
although
differ
pseudotyp
observ
wildtyp
aichiha
receptor
bindingincompet
mutant
diminish
bacteri
na
ad
studi
bosch
et
al
impli
chang
receptor
bind
properti
affect
pseudotyp
effici
lentivir
vector
influenza
ha
regard
potenti
influenc
mutat
posit
receptor
bind
properti
report
contradictori
result
first
yamada
et
al
found
mutat
chang
sialic
acid
bind
prefer
auewarakul
et
al
report
allow
dual
bind
acid
receptor
although
studi
effect
mutat
alon
assess
recent
use
viru
elut
assay
imai
colleagu
found
virus
contain
alanin
posit
show
stronger
bind
harbour
threonin
chicken
erythrocyt
express
acid
hors
erythrocyt
express
alpha
acid
similar
observ
imai
et
al
found
current
studi
contain
display
strong
bind
mdck
cell
express
increas
level
decreas
level
acid
parent
mdck
predict
observ
mutat
reduc
bind
dramat
lower
level
cell
line
like
strong
bind
cell
surfac
sialic
acid
receptor
make
difficult
releas
produc
cell
even
presenc
exogen
bacteri
na
mutat
reduc
bind
thu
allow
releas
keep
hypothesi
cotransfect
viral
na
gene
led
product
similar
amount
mix
hana
pseudoparticl
moreov
observ
increas
bind
cell
contain
acid
cell
surfac
fact
bind
slightli
lower
effici
compar
parent
mdck
cell
suggest
mutat
probabl
lead
decreas
bind
acid
rather
switch
acid
bind
consist
notion
observ
increas
level
product
sialylationdefici
cell
compar
parent
cho
cell
fig
found
mutat
exert
critic
influenc
determin
pseudotyp
effici
also
impact
virus
acambodia
two
differ
isol
carri
mutat
could
agglutin
human
guinea
pig
rbc
fail
agglutin
hors
rbc
also
figur
paper
wherea
two
strain
virus
without
mutat
could
also
agglutin
hors
rbc
figur
observ
indic
mutat
reduc
viru
bind
acid
although
cotransfect
viral
na
enabl
effici
lentivir
pseudotyp
fig
differenti
rbc
bind
properti
observ
whole
viru
level
ha
na
present
support
idea
mutat
biolog
relev
interestingli
alanin
posit
highli
conserv
avian
virus
far
mutat
found
human
isol
virus
clade
clade
virus
isol
almost
avian
isol
possess
ha
far
one
avian
viru
ncbi
databas
serin
instead
posit
ha
protein
notabl
divers
observ
posit
human
isol
virus
three
virus
isol
human
patient
threonin
eleven
valin
posit
least
two
case
virus
found
origin
patient
specimen
mixtur
wild
type
contain
ha
mutant
viru
contain
possibl
human
isol
virus
may
actual
contain
mutat
fail
detect
process
either
viru
isol
tradit
capillari
sequenc
viral
genom
thousand
sequenc
avail
ncbi
influenza
databas
http
wwwncbinlmnihgov
genomesflufluhtml
nonhuman
isol
virus
none
contain
particular
mutat
altogeth
observ
suggest
valin
residu
receptorbind
domain
unlik
random
sequenc
variat
may
select
avian
virus
adapt
replic
human
host
specul
gener
term
chang
cell
surfac
receptor
bind
result
mutat
may
lead
chang
viru
entri
viru
releas
therefor
consid
import
factor
determin
host
rang
clear
whether
intracellular
sialic
acid
content
distribut
may
also
influenc
featur
data
focu
pseudotyp
system
studi
requir
understand
precis
biolog
consequ
mutat
potenti
influenc
adapt
virus
human
find
also
implic
applic
assay
serolog
survey
sever
advantag
microneutr
method
current
gold
standard
serolog
assay
detect
antibodi
avian
influenza
virus
pseudotyp
particl
produc
synthet
gene
without
need
access
viru
safe
use
contain
make
ideal
widespread
use
especi
area
facil
avail
moreov
report
assay
sensit
microneutr
appear
howev
use
seroepidemiolog
studi
monitor
efficaci
candid
vaccin
may
limit
strain
investig
although
other
found
product
mix
hana
pseudoparticl
consist
success
use
either
also
fig
paper
product
haonli
pseudotyp
would
necessari
elimin
potenti
crossreact
may
display
circul
antina
antibodi
avian
season
influenza
cogniz
singl
mutat
may
result
chang
antigen
limit
differ
microneutr
assay
goldstandard
detect
neutral
antibodi
util
avail
viru
strain
may
perfect
match
virus
associ
serum
sampl
test
fact
serolog
survey
often
use
collect
serum
sampl
human
anim
without
necessarili
know
exact
viru
strain
involv
moreov
posit
sampl
shall
contain
polyclon
antibodi
multipl
epitop
viru
minim
likelihood
singl
amino
acid
substitut
would
compromis
use
pseudotypebas
serolog
assay
safer
altern
microneutr
test
care
assess
assay
obvious
perform
new
strain
emerg
conclus
compar
abil
differ
produc
pseudotyp
particl
demonstr
singl
mutat
introduc
receptor
bind
site
abil
usual
ineffici
gener
larg
restor
like
mutat
lead
increas
level
cell
surfac
ha
express
reduc
bind
sialic
acid
receptor
contribut
product
mutat
report
natur
occur
mutat
human
host
importantli
mutat
far
found
human
isol
virus
data
hemagglutin
assay
demonstr
viral
isol
human
case
avian
influenza
carri
substitut
exhibit
reduc
bind
link
sialic
acid
therefor
result
may
implic
understand
human
host
adapt
avian
influenza
virus
possibl
mutat
lead
reduct
receptor
bind
may
exist
caus
chang
pseudotyp
effici
thu
product
togeth
solubl
ha
protein
cell
bind
analysi
may
serv
conveni
function
assay
screen
mutat
potenti
consequ
receptor
bind
properti
host
adapt
virus
although
zoonot
transmiss
poultri
human
remain
ineffici
may
import
monitor
close
mutat
region
receptor
bind
site
mdck
cho
cell
line
obtain
atcc
manassa
va
usa
cell
gener
stabl
transfect
human
mdck
cell
describ
elsewher
cell
line
overexpress
sialic
acid
compar
parent
mdck
mdck
cho
cell
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
fb
invitrogen
penicillinstreptomycin
cell
grown
dmem
contain
fb
mgml
cell
lack
termin
sialic
acid
glycoprotein
gangliosid
due
defect
cmpsialic
acid
transport
cultur
minimum
essenti
medium
memalpha
invitrogen
supplement
fb
ugml
lprolin
see
also
ref
mutant
tabl
gene
synthes
human
codon
optim
gene
genearth
regansburg
germani
subclon
mammalian
express
vector
invitrogen
mutant
gener
sitedirect
mutagenesi
use
quikchang
sitedirect
mutagenesi
kit
stratagen
santa
clara
ca
usa
accord
manufactur
instruct
gener
solubl
construct
transmembran
domain
tmd
ha
remov
polybas
cleavag
site
chang
monobas
cleavag
site
resr
sitedirect
mutagenesi
avoid
potenti
influenc
cleavag
cell
purif
sha
protein
involv
multipl
step
truncat
subclon
invitrogen
plasmid
tag
flagepitop
ctermin
sequenc
confirm
contain
expect
mutat
indic
tabl
product
lentivir
particl
pseudotyp
hemagglutinin
perform
previous
describ
briefli
cell
cotransfect
plasmid
contain
code
sequenc
indic
lentivir
backbon
plasmid
pnlluc
carri
modifi
provir
genom
hiv
env
delet
engin
express
firefli
luciferas
report
altern
mlvbackbon
plasmid
kind
gift
dr
michael
farzan
harvard
medic
school
describ
use
indic
releas
particl
cultur
medium
either
solubl
bacteri
na
vibrio
cholera
navb
roch
mannheim
germani
ad
produc
cell
concentr
muml
cotransfect
gene
use
indic
supernat
contain
harvest
hr
posttransfect
filter
use
transduc
mdck
cell
luciferas
report
activ
assay
concentr
ultracentrifug
indic
luciferas
report
activ
assay
mdck
cell
cellswel
seed
white
assay
plate
one
day
transduct
luciferas
report
activ
assay
perform
hr
post
transduct
use
brightglow
luciferas
substrat
promega
mandison
wi
usa
accord
manufactur
instruct
sampl
measur
use
microbeta
luminomet
perkinelm
waltham
usa
data
express
rel
luminesc
unit
equal
amount
protein
total
cell
lysat
equal
volum
concentr
ultracentrifug
subject
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
protein
transfer
onto
hybondp
polyvinyliden
difluorid
pvdf
membran
invitrogen
block
milk
min
room
temperatur
detect
incub
hr
room
temperatur
mous
monoclon
antiflag
antibodi
sigma
stloui
mo
usa
dilut
conjug
hors
radish
peroxidas
hrp
sigma
core
protein
pseudotyp
particl
detect
use
antibodi
abcam
cambridg
uk
hr
room
temperatur
dilut
follow
addit
hr
incub
goatantimous
secondari
antibodi
conjug
hrp
zymedh
invitrogen
dilut
level
cyclophilin
b
detect
rabbit
anticyclophilin
b
antibodi
abcam
dilut
gapdh
detect
mous
antigapdh
antibodi
abcam
dilut
measur
blot
verifi
equal
amount
sampl
transfer
protein
visual
chemiluminesc
use
ecl
western
blot
detect
reagent
invitrogen
rel
electrophoret
mobil
estim
use
novexh
sharp
prestain
protein
standard
invitrogen
cell
transfect
ha
detach
resuspend
pb
block
hors
serum
label
polyclon
rabbit
antibodi
sino
biolog
inc
beij
china
dilut
hr
unbound
antibodi
remov
wash
three
time
cold
pb
follow
stain
phycoerythrin
pe
conjug
donkeyantigoat
secondari
antibodi
jackson
immunoresearch
laboratori
suffolk
uk
min
data
collect
least
cell
lsrii
flow
cytomet
bd
bioscienc
franklin
lake
nj
usa
postacquisit
analys
cell
surfac
express
perform
use
flowjo
softwar
treestar
ashland
usa
express
purif
solubl
protein
cell
stabli
express
solubl
ha
sha
protein
gener
select
transfect
cell
cultur
medium
contain
ugml
hygromycin
least
month
purifi
sha
protein
cell
grown
dmem
fb
confluenc
cultur
supernat
contain
secret
sha
protein
clear
centrifug
rpm
minut
concentr
amicon
centrifug
filter
unit
membran
millipor
billerica
usa
kda
cutoff
store
use
solubl
ha
protein
affin
purifi
concentr
supernat
use
antiflag
affin
gel
sigma
shown
habound
sialic
acid
could
interfer
access
receptorbind
site
cellular
receptor
antiflag
resin
bound
sha
protein
wash
twice
cold
pb
subject
treatment
navb
roch
muml
minut
remov
termin
sialic
acid
residu
follow
three
wash
cold
pb
bound
sha
protein
elut
ml
flag
peptid
intern
laboratori
usa
mgml
pb
four
time
remov
flag
peptid
eluat
pool
concentr
use
amicon
ml
membran
millipor
kda
cutoff
examin
oligomer
state
sha
protein
resolv
discontinu
nativ
page
acrylamid
follow
western
blot
detect
use
hrpconjug
antiflag
antibodi
sigma
cellbas
ha
bind
assay
mdck
cell
grown
plate
complet
confluenc
fix
paraformaldehyd
pfa
sigma
wash
three
time
pb
block
least
hr
bsa
indic
amount
purifi
solubl
ha
protein
measur
bradford
assay
ad
well
duplic
triplic
incub
overnight
cell
wash
three
time
pb
incub
antiflag
antibodi
origen
rockvil
md
usa
dilut
hr
room
temperatur
detect
sha
protein
bound
cell
surfac
wash
three
time
pb
remov
unbound
sha
protein
cell
incub
goatantimous
secondari
antibodi
conjug
hrp
zymedh
invitrogen
dilut
hr
room
temperatur
unbound
secondari
antibodi
remov
wash
three
time
pb
abt
substrat
invitrogen
ad
plate
accord
manufactur
instruct
forti
minut
addit
substrat
absorb
nm
measur
use
sunris
tm
plate
reader
tecan
nnedorf
switzerland
cambodian
viru
strain
isol
human
clinic
specimen
inocul
madindarbi
canin
kidney
mdck
cell
biosafeti
level
laboratori
institut
pasteur
cambodia
accord
convent
protocol
hemagglutin
titr
measur
use
suspens
human
type
hors
guinea
pig
red
blood
cell
previous
describ
result
present
mean
valu
sd
indic
number
observ
statist
differ
group
determin
unpair
student
ttest
signific
level
